CNS Pharmaceuticals (CNSP) Research & Development (2019 - 2025)
CNS Pharmaceuticals' Research & Development was $3.17 million in Q4 2025, up 111.3% from $1.5 million a year earlier and up 44.1% from the prior quarter.
Powered by 
Analysis
CNS Pharmaceuticals (CNSP) Research & Development (2019 - 2025) Analysis & Trends
For FY2025, Research & Development at CNS Pharmaceuticals came in at $9.77 million, up 5.2% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 14.1% (FY2020 to FY2025).
- In earlier years, Research & Development was $9.29 million in FY2024 (-34.1%), $14.1 million in FY2023 (+51.6%), $9.3 million in FY2022 (-5.2%) and $9.81 million in FY2021 (+93.7%).
- Quarterly Research & Development has moved between $1.12 million (Q2 2024) and $4.27 million (Q4 2023) over five years.
- Compared with a year earlier, Research & Development was higher in four of the last eight quarters, with an average decline of 4.0%.
- The best year-over-year quarter for Research & Development over five years was Q1 2021 (growth of 260.0%); the worst was Q4 2024 (a decline of 64.9%).
- Per Business Quant data, CNSP's Research & Development in the three quarters before Q4 2025 was $2.2 million (Q3 2025), $1.17 million (Q2 2025) and $3.24 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | CNS Pharmaceuticals | 2.30 Mn | -39.94 Mn | - | 3.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.17 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 4.27 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Jun 30, 2023 | 2.85 Mn |
| Mar 31, 2023 | 3.57 Mn |
| Dec 31, 2022 | 2.98 Mn |
| Sep 30, 2022 | 2.21 Mn |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | 2.66 Mn |
| Mar 31, 2021 | 2.21 Mn |
API Access
CNS Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CNSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CNSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CNSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();